InscoBio, a KOSPI-listed company (CEO Insoo Yoo and Jagap Koo), announced on the 17th that it has obtained approval from the Ministry of Food and Drug Safety (MFDS) for the resale of ‘Apitoxin,’ a ...
InscoBi is focusing its capabilities on the bio business sector as it resumes production of Apitoxin, a natural product-derived osteoarthritis pain treatment, through its new drug development ...
Hosted on MSN
Bee venom effects on vascular system demonstrated
A study led by the Universitat Autònoma de Barcelona (UAB) shows that bee venom apitoxin alters the functioning of blood vessels, even at low concentrations. Researchers also identified an important ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback